By The Associated Press
SALES JUMP: Powered by demand for its cancer drugs, Swiss drugmaker Roche on Tuesday reported a 7 percent increase in sales of its pharmaceutical products for the first nine months of 2012.
THE DETAILS: The world's biggest producer of cancer-fighting drugs said its pharmaceutical division's sales over the three quarters rose to 26.2 billion Swiss francs ($28.08 billion), from 24.4 billion francs in the same time period last year.
CANCER DRUGS: The company, based in Basel, Switzerland, had solid growth in its top three cancer drugs - MabThera/Rituxan, Herceptin and Avastin, which it said accounted for 52 percent of the division's sales.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.